PLXPQ — PLx Pharma Winddown Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsHighly SpeculativeMicro CapValue Trap

Annual balance sheet for PLx Pharma Winddown, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	24.4	14.3	14	22.4	69.4
Net Total Accounts Receivable
Net Total Receivables	0.019	0.018	0.019	0	0.634
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	25.7	14.9	14.3	23	73.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.03	1.39	2.08	1.55	1.09
Net Goodwill
Other Long Term Assets
Total Assets	28.8	18.4	18.5	26.6	76.6
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.82	4.73	6.09	3.54	11.9
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	24.2	11.9	16.9	16.2	25
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	4.62	6.44	1.57	10.5	51.7
Total Liabilities & Shareholders' Equity	28.8	18.4	18.5	26.6	76.6
Total Common Shares Outstanding
Total Preferred Shares Outstanding